In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
This report contains market size and forecasts of Non-Oncology Precision Medicine in Global, including the following market information:
Global Non-Oncology Precision Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Oncology Precision Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Applied Sciences Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Oncology Precision Medicine include Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group, AstraZeneca PLC, Bristol Myers Squibb, bioMérieux SA., BGI and Danaher Corp., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Oncology Precision Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Oncology Precision Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Oncology Precision Medicine Market Segment Percentages, by Type, 2021 (%)
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Global Non-Oncology Precision Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-Oncology Precision Medicine Market Segment Percentages, by Application, 2021 (%)
Infectious Diseases
Neurology
Cardiovascular
Lifestyle and Endocrinology
Gastroenterology
Others
Global Non-Oncology Precision Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-Oncology Precision Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Oncology Precision Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Oncology Precision Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies, Inc.
Asuragen, Inc.
Almac Group
AstraZeneca PLC
Bristol Myers Squibb
bioMérieux SA.
BGI
Danaher Corp.
Illumina, Inc.
Invitae Corporation
Opko Health, Inc.
Teva Pharmaceutical Industries Ltd.